Virtus LifeSci Biotech Clinical Trials ETF (BBC) Chart & Stock Price History $21.01 -0.01 (-0.05%) As of 01:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Stock Price Performance The Virtus LifeSci Biotech Clinical Trials ETF (BBC) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 19.01%, with a year-to-date return of -12.24%. In the past month, the fund has increased 3.34%, reflecting recent market activity. As of the latest close, Virtus LifeSci Biotech Clinical Trials ETF traded at $21.02 with a market cap of $14.71 million and volume of 18,199 shares. Five years ago, the fund traded at $41.33, representing a 49.17% decrease over that period. At the time, it had a market cap of $47.32 million and a volume of 19,811 shares. Receive BBC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.05%1 Month Performance+3.34%3 Month Performance+19.72%Year-To-Date Performance-12.24%1 Year Performance-19.01%5 Year Performance-49.17% BBC Stock Chart for Friday, August, 8, 2025 BBC Chart by TradingView Virtus LifeSci Biotech Clinical Trials ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$21.56$21.02-2.50%$21.62$20.9118,199 shs$14.71 million08/06/2025$21.98$21.56-1.91%$21.58$21.2212,968 shs$15.09 million08/05/2025$21.73$21.98+1.15%$22.02$21.6311,736 shs$15.39 million08/04/2025$21.45$21.73+1.31%$21.79$21.2215,192 shs$15.21 million08/01/2025$21.66$21.45-0.97%$21.57$21.1829,670 shs$15.02 million07/31/2025$22.13$21.66-2.12%$22.13$21.6028,640 shs$15.16 million07/30/2025$21.85$22.13+1.28%$22.72$21.94142,065 shs$15.49 million07/29/2025$22.40$21.85-2.46%$22.22$21.7720,899 shs$14.20 million07/28/2025$22.23$22.40+0.76%$22.78$22.2719,695 shs$14.56 million07/25/2025$22.28$22.23-0.22%$22.33$21.8313,521 shs$14.45 million Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$22.43$22.28-0.67%$22.51$22.0964,995 shs$14.48 million07/23/2025$21.71$22.43+3.32%$22.58$21.8086,534 shs$14.58 million07/22/2025$21.64$21.71+0.32%$21.72$21.37119,382 shs$14.11 million07/21/2025$21.60$21.64+0.19%$22.25$21.6116,551 shs$14.07 million07/18/2025$21.88$21.60-1.28%$22.31$21.6122,606 shs$14.04 million07/17/2025$21.59$21.88+1.34%$22.04$21.7310,726 shs$13.13 million07/16/2025$21.07$21.59+2.47%$21.60$21.0912,061 shs$12.95 million07/15/2025$21.69$21.07-2.86%$21.76$21.009,813 shs$12.64 million07/14/2025$21.19$21.69+2.36%$21.81$21.3020,167 shs$11.93 million07/11/2025$21.53$21.19-1.58%$21.45$21.1914,859 shs$11.65 million07/10/2025$21.59$21.53-0.28%$21.60$21.0248,931 shs$11.84 million07/09/2025$20.33$21.59+6.20%$21.69$20.6191,764 shs$11.87 million07/08/2025$19.99$20.33+1.70%$20.55$20.21168,077 shs$11.18 million07/07/2025$20.32$19.99-1.62%$20.33$19.8718,082 shs$10.99 million Related Companies FTXH Stock Chart MEDX Stock Chart MEDI Stock Chart GDOC Stock Chart TMED Stock Chart PILL Stock Chart JDOC Stock Chart BBP Stock Chart LGHT Stock Chart HYLG Stock Chart Receive BBC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:BBC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
